Company
Xaira Therapeutics
Xaira Therapeutics is a biotechnology company based in South San Francisco that uses artificial intelligence to accelerate drug discovery and development. The company integrates machine learning research, large-scale biological data generation, and therapeutic product development to advance drug discovery. Founded in 2023, Xaira develops foundational technologies including X-Cell and X-Atlas/Pisces platforms designed to improve how diseases are understood and treated.
Xaira Therapeutics is a privately held company operating in the biotech & pharma sector, based in USA. Leadership tracked by CEOInsider includes Marc Tessier-Lavigne (CEO).
Leadership
Current
